We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Lipoxen to Develop Improved Delivery of Antiviral Drugs for the Treatment of Liver Disease Caused by Hepatitis C

Lipoxen joins with Nottingham University to deliver antiviral drugs direct to the liver by means of nanoparticles for the treatment of viral hepatitis.
News

Canopus BioPharma Announces Positive Results in Human Study of Peptide Cancer Vaccine

Study analyzed at Southern Research Institute shows human antibodies generated by Canopus’s peptides have anti-cancer properties.
News

CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine

The new agreement extends the Multikine collaboration to also cover South Korea, the Philippines, Australia and New Zealand.
News

Neovacs Begins a Phase I/II Clinical Trial for the Treatment of Crohn’s Disease

Neovacs commences the study at three study centres in South Africa with the candidate TNFa-kinoid.
News

Researchers from Applied Biosystems and the University of Ghent Demonstrate Megaplex™ miRNA Profiling Tools

Study describes simultaneous profiling of 450 human microRNAs from samples as small as a single cell.
News

Wolters Kluwer Health's Prescription Data Tapped by FDA in Effort to Advance Drug Safety

Multi-Year contract to provide U.S. drug utilization patterns allows FDA to evaluate unexpected market events.
News

AltheaDx to Offer the DxS K-RAS Test for Clinical Studies

DxS K-RAS test will assist US oncologists in studying patient response to cancer therapies in clinical trials.
News

Agilent Technologies, BioTrove to Streamline Drug Discovery Using High-Throughput Mass Spectrometry

Reseller agreement expands existing co-marketing relationship and provides a complete solution for enhanced screening of pharmaceutical compounds.
News

Evotec Reports Phase I Safety Data from Tyramine Interaction Study with EVT 302

The study was undertaken to determine potential safety advantages of EVT 302 versus non-selective MAO inhibitors and less selective MAO-B inhibitors.
News

High Throughput Imaging Speeds Analysis of Hormone Receptors

A new high throughput microscopy technique enabled researchers at Baylor College of Medicine to analyze thousands of individual cells expressing androgen receptor.
Advertisement